SCHEMBL7769229

SCHEMBL7769229

COc1ccccc1N1CCN(CC(N)c2nc3c(Cl)cccc3s2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.46
ADRA1D P25100 3/20 0.45
ADRA1A P35348 3/20 0.45
ADRA1B P35368 3/20 0.45
MAPT P10636 7/20 0.45
LMNA P02545 4/20 0.45
KDM4E B2RXH2 3/20 0.45
MAPK1 P28482 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HIF1A Q16665 2/20 0.45
DRD1 P21728 2/20 0.45
DRD3 P35462 2/20 0.45
DRD2 P14416 2/20 0.45
NR1I2 O75469 1/20 0.45
NR3C1 P04150 1/20 0.45
ADRB1 P08588 1/20 0.45
HTR1A P08908 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7769211 0.99 HTR7 (0.45) HTR7ADRA1DADRA1AADRA1BMAPT
SCHEMBL7769227 0.92 ALDH1A1 (0.48) ADRA1DADRA1AADRA1BMAPTLMNA
Bromide SCHEMBL7773368 0.91 ALDH1A1 (0.47) ADRA1DADRA1AADRA1BMAPTLMNA
SCHEMBL7773359 0.89 HTR2A (0.47) HTR7ADRA1DADRA1AADRA1BMAPT
Bromide SCHEMBL7773413 0.89 HTR2A (0.46) HTR7ADRA1DADRA1AADRA1BMAPT
SCHEMBL7769221 0.85 DRD2 (0.48) ADRA1DADRA1AADRA1BMAPTLMNA
SCHEMBL27568494 0.83 KDM4E (0.47) MAPTLMNAKDM4EMAPK1ALDH1A1
Bromide SCHEMBL27577479 0.82 KDM4E (0.46) MAPTLMNAKDM4EMAPK1ALDH1A1
SCHEMBL7984291 0.81 TSHR (0.44) HTR7ADRA1DADRA1AADRA1BMAPT
SCHEMBL7769235 0.79 HTR7 (0.44) HTR7ADRA1DADRA1AADRA1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed